key: cord-0727140-jehvhxdt
authors: Greco, Giada Ida; Noale, Marianna; Trevisan, Caterina; Zatti, Giancarlo; Pozza, Martino Dalla; Lazzarin, Martina; Haxhiaj, Labjona; Ramon, Roberto; Imoscopi, Alessandra; Bellon, Stefano; Maggi, Stefania; Sergi, Giuseppe
title: Increase in frailty in nursing home survivors of COVID-19: comparison with non-infected residents
date: 2021-02-22
journal: J Am Med Dir Assoc
DOI: 10.1016/j.jamda.2021.02.019
sha: 6950dd4180dbb51c3acb3764e4df28b558b99cd4
doc_id: 727140
cord_uid: jehvhxdt

Objectives Institutionalized older adults have a high prevalence of frailty and disability, which may make them more vulnerable to the negative consequences of COVID-19. We investigated the impact of COVID-19 on the level of frailty, physical and cognitive performance in nursing home residents. Design Nested case-control study. Setting and participants. The study included nursing home residents who were infected with COVID-19 (case group, n=76), matched by age to a control group (n=76). Methods Participants’ sociodemographic and medical data were collected, and they were also assessed for physical function (handgrip and walking speed), cognitive performance (Mini-Mental State Examination [MMSE]) and frailty (Frail-NH scale) before the first wave of the COVID-19 pandemic (October to December 2019, "pre-COVID-19") and after (June to July 2020, "post-COVID-19"). COVID-19 symptoms and clinical course were recorded for the cases. Results Between the pre- and post-COVID-19 assessments, we found a 19% greater deterioration in handgrip, a 22% greater increase in walking speed, and a 21% greater increase in Frail-NH scores in cases compared with controls. In both cases and controls, on the other hand, there was a significant 10% decrease in MMSE scores over the study period. Multivariable logistic regression showed that COVID-19 survivors had a four-fold increased chance of developing frailty compared with controls (OR = 4.95, 95% CI: 1.13-21.6, p=0.03), but not cognitive decline. Conclusions and implications COVID-19 can accelerate the aging process of institutionalized older adults in terms of physical performance and frailty by around 20%. However, we found similar levels of decline in cognitive performance in both cases and controls, likely due to the burden of social isolation and containment measures on neuropsychological health.

them more vulnerable to the negative consequences of COVID-19. We investigated the impact of COVID-19 23 on the level of frailty, physical and cognitive performance in nursing home residents. 24

Design. Nested case-control study. 25

Setting and participants. The study included nursing home residents who were infected with COVID-19 26 (case group, n=76), matched by age to a control group (n=76). 27

Methods. Participants' sociodemographic and medical data were collected, and they were also assessed for 28 physical function (handgrip and walking speed), cognitive performance (Mini-Mental State Examination 29

[MMSE]) and frailty (Frail-NH scale) before the first wave of the COVID-19 pandemic (October to 30

December 2019, "pre-COVID-19") and after (June to July 2020, "post-COVID-19"). COVID-19 symptoms 31

and clinical course were recorded for the cases. 32

Results. Between the pre-and post-COVID-19 assessments, we found a 19% greater deterioration in 33 handgrip, a 22% greater increase in walking speed, and a 21% greater increase in Frail-NH scores in cases 34 compared with controls. In both cases and controls, on the other hand, there was a significant 10% decrease 35

in MMSE scores over the study period. Multivariable logistic regression showed that COVID-19 survivors 36 had a four-fold increased chance of developing frailty compared with controls (OR = 4.95, 95% CI: 1.13-37 21.6, p=0.03), but not cognitive decline. 38

Conclusions and implications. COVID-19 can accelerate the aging process of institutionalized older adults 39 in terms of physical performance and frailty by around 20%. However, we found similar levels of decline in 40 cognitive performance in both cases and controls, likely due to the burden of social isolation and 41 containment measures on neuropsychological health.

The older population has been shown to be highly vulnerable to the negative consequences of SARS-CoV-2 48 infection 1,2 . In Italy, the mean age of individuals who have died from COVID-19 is 80 years, and the oldest 49 age groups have the highest lethality rate 3 . Moreover, the presence of frailty, a common condition in older 50 age 4 , has been associated with atypical presentation and a more severe course of SARS-CoV-2 infection 5 , 51

including increased mortality 6 . Frailty is especially frequent in nursing homes, where its prevalence can be 52 as much as 75% 7 . These are therefore settings where there is not only a high risk of contagion due to 53 logistical characteristics (e.g. shared living environments), but also a high risk of complications that can 54 affect their residents 8 . 55

In recent months, several studies have investigated SARS-CoV-2 infection in institutionalized individuals, 56 focusing on contagion, clinical presentation, and mortality 1, [9] [10] [11] . However, there is still a lack of evidence 57 regarding the extent to which the pandemic has affected the cognitive and physical performance of such a 58 vulnerable population, in particular those having survived COVID-19. The negative impact of the COVID-59 19 pandemic on the health of nursing home residents could be a direct result of the disease, but may also be 60 an indirect result of the implementation of preventive measures, such as physical distancing, the restriction of 61 informal visits, and lack of cognitively-and physically-stimulating activities. In these ways, the COVID-19 62 pandemic might overall have accelerated the aging process of institutionalized individuals. The degree of this 63 acceleration with regard to different health parameters and the actual impact of COVID-19 per se could be 64 estimated by evaluating the changes in individual performances before and after the disease, and comparing 65 them with the changes in people not affected by Although in most cases the rapid spread of the pandemic did not allow individuals to be evaluated before the 67 disease, for the present study we were able to use the evaluations of residents involved in a pilot study on

We designed a nested case-control study based on the cohort involved in an ongoing study ("Pilot study on 77 the burden of influenza in the nursing home") being conducted in the [blinded for review] nursing home in 78 the city of Padua (Italy). For this pilot study, 418 residents underwent a multidimensional assessment by 79 experienced geriatric physicians between October and December 2019. Of that sample, 382 individuals were 80 still resident in the nursing home in March 2020, 76 of whom became infected with SARS-CoV-2 up to May 81 15, 2020, and were therefore recruited as cases in the present study. We selected 76 controls matched to the 82 cases by age ± 3 years from those residents who were not infected by SARS-CoV-2 and were still alive up to 83

June 2020. Among the cases, 20 residents (26.3%) deceased from March to July 2020, and 56 underwent the 84 post-COVID-19 assessment (the study flow-chart is shown in Figure A1 ). The study was approved by the 85 local Ethics Committee of the [blinded for review] nursing home, and participants (or their next of kin) gave 86 their written consent to participate in the study. 87

Data pertinent to the pre-COVID-19 phase were collected between October and December 2019 and 89 included sociodemographic information, medical history, use of drugs, and vaccinations in the last year. 90

Patients' comorbidity levels were evaluated through the Cumulative Illness Rating scale (CIRS) Comorbidity 91

Index and Severity Index. The Comorbidity Index indicates the number of disease categories out of the first 92 13 (excluding psychiatric/behavioral illnesses) rated as moderate to severe to obtain a score ranging from 0 93 to 13. The Severity Index is the average score of the ratings of the first 13 disease categories evaluated in the 94 CIRS 12 . Frailty status was assessed through the Frail-NH scale, a validated tool for nursing homes that 95 evaluates seven domains, i.e. fatigue, resistance, ambulation, incontinence, weight loss, nutritional approach, 96 and help with dressing, to obtain a total score ranging from 0 to 14 points 13 . In the present study, total Frail-97 NH scores were used to classify residents as non-frail (≤7) or frail (>7), according to Kaehr et al. 13 ; and as 98 non-frail (0-1 points), mild-to-moderate frail (2-5), and most frail (6-14), according to Theou et al. 14 . 99 out for each hand, and grip strength was calculated as the mean of the maximum performance at the 102 dominant and non-dominant hand; 103 -walking speed (m/s), measured through the 4-meter usual-pace walking test. The test was performed two 104 times consecutively. The best time necessary to cover the established distance was used for our assessment 105 of walking speed 15 . 106

As regards cognitive performance, we considered the Mini-Mental State Examination (MMSE), a validated 107 scale ranging from 0 (worse) to 30 (best cognitive performance) 16 , estimating global cognitive function. 108

Diagnostic testing for SARS-CoV-2 infection in the nursing home has been performed through 109 nasopharyngeal swab since March 2020, when the first COVID-19 case was registered in a resident. 110

Surveillance testing of all residents by the same method was carried out every 15-20 days in accordance with 111 local health authority policies, in addition to testing of residents who presented with COVID-19 symptoms 112 (fever, respiratory symptoms) or who had been in contact with infected individuals. The clinical presentation 113 and mortality of COVID-19 cases was also recorded. 114

In the post-COVID-19 phase of the study, between June and July 2020, participants were assessed for frailty 115 status, handgrip strength, walking speed and cognitive function using the same methods described for the 116 pre-COVID-19 phase. 117

Controls were matched to cases by age ± 3 years using the SAS GMATCH macro 17 . 119

The sample characteristics are expressed as counts and percentages for the categorical variables, and as 120 means ± standard deviations (SD) or medians (interquartile range, IQR) for the continuous variables. 121

Differences between the characteristics of cases and controls were evaluated using the paired Student t-test 122 or the Wilcoxon signed-rank test for the continuous variables, and conditional logistic regression for 123 categorical variables, as appropriate. The characteristics associated with the incidence of frailty evaluated 124 with the Frail-NH scale were assessed by logistic regression models. 125

Changes in MMSE scores, handgrip, walking speed and the Frail-NH scale pre-vs post-COVID-19 in the 126 case and control groups were analyzed using mixed models for repeated measures, adjusting for the within-(defined as a drop in MMSE score ≥2 points) were assessed through logistic regression. 129

Statistical analyses were performed using the SAS 9.4 software. 130

The baseline characteristics of cases (only survivors) and controls are reported in Table 1 (for the baseline 133 characteristics of all COVID-19 cases and controls, please see Table A1 ). As shown, at the pre-COVID-19 134 assessment, cases and controls differed only in the prevalence of upper gastro-intestinal, and musculoskeletal 135 and skin pathologies, which were higher in the control group. Although the two groups had a similar 136 prevalence of frailty at baseline, single-item frailty measures showed that COVID-19 survivors were more 137 likely to have better mobility levels than controls, with 34% vs 19%, respectively, able to stand up 138 independently (p = 0.011), and 38% vs 23%, respectively, able to move in and out of the facility 139 autonomously (p = 0.057). 140

Considering both COVID-19 cases who survived and those who did not (n=76), we found that almost half 141 (49%) presented with at least one symptom, the most frequent being fever (61.5%), low-grade fever (23.1%), 142 dyspnea (43.6%), cough (28.2%), fatigue (7.7%), cold (5.1%), myalgia and arthralgia (2.6%), and diarrhea 143

(2.6%). There were marginally significant differences in the prevalence of frailty at baseline between 144 symptomatic and asymptomatic COVID-19 cases (Table A2) . 145 Table 2 shows the estimated within-and between-group differences in MMSE, Frail-NH, handgrip strength, 146 and walking speed obtained from repeated measures models. In the group of COVID-19 survivors (average 147 time interval between infection and post-COVID-19 assessment: 92±10 days), we found significant 148 worsening in MMSE, Frail-NH, and walking speed from the pre-to the post-COVID-19 phases, and 149 borderline significant changes in handgrip strength. Among the controls, only MMSE worsened significantly 150 from the pre-to the post-COVID-19 phases. As Figures A2 and A3 show, there were significant differences 151 between cases and controls in the extent of the changes in Frailty-NH, handgrip strength, and walking speed 152 during the observation period, with a steeper worsening in the former group. In particular, we found a 21% 153 greater increase in frailty scores in cases compared with controls, and 19% and 22% greater reductions in test at the post-COVID-19 phases (for details, please see Appendix 1), as well as in the MMSE variations. 157

Moreover, considering the study cases, we found that the changes in MMSE, physical performance, and 158 frailty did not significantly correlate with the number of days between the COVID-19 episode and the post-159 COVID-19 assessment (data not shown). 160

The cumulative incidence of frailty over the study period was 38% (46.2% among cases, 29.2% among 161 controls) using the Kaehr et al. cut-off 13 ; and 53.4% (75% among cases, 28.6% among controls) using the 162 Theou et al. cut-off 14 . As reported in Table 3 , logistic regression showed that having been infected with 163 COVID-19 was associated with a four-fold higher chance of developing frailty (OR = 4.95, 95% CI: 1.13-164 21.6, p = 0.03). Single-item Frail-NH measures (data not shown) showed that COVID-19 increased the 165 chance of experiencing a loss in weight ≥10% of normal weight (OR = 5.47, 95% CI: 1.66-18.0, p = 0.005). 166

Cognitive decline, defined as a reduction in MMSE score ≥2 points from the pre-to the post-COVID-19 167 phases, was observed in 14 cases (36.8%) and 17 controls (32.7%), with no differences between groups (p = 168 0.41). Multivariable logistic regression (Table 3) showed that the factors significantly associated with 169 cognitive decline were frailty and comorbidity, but not COVID-19. 170

Our study shows that COVID-19 may accelerate age-related deterioration in the physical performance and 173 frailty status of nursing home residents by around 20%. Furthermore, the preventive measures associated 174 with the COVID-19 pandemic that limited social interaction and cognitively-/physically-stimulating 175 activities seemed to impact on cognitive function similarly in individuals who were infected with SARS-176

CoV-2 and those who were not. 177

Regarding mortality, 26.3% of our COVID-19 cases died over the observation period (80% of these due to 178 COVID-19, 20% to other diseases), in line with previous studies 6, 9, 18 . However, the disease also placed a 179 substantial burden on the health of COVID-19 survivors. Indeed, the latter showed a greater reduction in 180 walking speed and muscle strength, and a higher chance of frailty developing and worsening than controls, 181 with negative effects especially on nutritional status and psychological well-being. With respect to the 182 changes in physical performance and frailty from the pre-to the post-COVID-19 phases, we found that compared with controls. 185

First of all, it is well-known that both acute and chronic inflammation can negatively affect muscle strength 187 and performance. SARS-CoV-2 infection, in particular, induces a severe inflammatory response 188 characterized by cytokine storm that drives systemic inflammation 19 . Previous studies have demonstrated 189 that acute inflammatory status can cause a reduction in muscle mass and strength, mainly due to protein 190 catabolism upregulation and concurrent anabolism downregulation, which overall lead to decreased muscle 191 protein synthesis 20,21 . These effects may be more marked in older individuals who already present with 192 chronic inflammation (inflammaging), which in the long term can negatively affect multiple organs and 193 systems, including the musculoskeletal system 22,23 . 194 Second, reduced mobility or immobilization plays an important role in the loss of muscular mass and 195 strength 21,24 . In this regard, it has been shown that two days in bed reduces muscle mass by around 1. 7%, 196 increasing to 5.5% after only 7 days 25 . As a consequence of the ongoing acute disease and in order to 197 prevent contagion, individuals with a positive SARS-Cov-2 swab test moved around less and were unable to 198 benefit from individual and group physical rehabilitation programs, as these had been suspended. 199 Third, preventive measures to limit contagion in the nursing home also entailed a reduction in psychological 200 counseling, which, on top of the ban on visits from informal caregivers and physical distancing, led to 201 increased feelings of loneliness and depression. The erosion of psychological well-being is a further factor 202 affecting physical performance, as already demonstrated for depression 26 . 203 Concerning cognitive function, our study did not reveal any differences between COVID-19 survivors and 204 controls in terms of loss of cognitive performance. Both groups exhibited an average reduction in MMSE 205 scores of 1.7 points over the observation period, and the chance of undergoing cognitive decline was not 206 significantly associated with COVID-19. In this regard, comparing our results with data on people with 207 cognitive disorders 27,28 , we cannot rule out that a similar cognitive decline would have also been experienced 208

irrespective of the COVID-19 pandemic. However, the fact that we found no differences in the cognitive 209 decline between cases and controls suggests that the possible burden attributable to preventive measures and 210 social restriction could have involved all the nursing home residents. Nonetheless, we cannot exclude the therefore support the need to closely monitor the cognitive status of COVID-19 patients over time to identify 213 possible subsequent decline 29 . 214

The main strength of this work lies in the availability of data from a pre-COVID-19 assessment carried out in 215 the context of another ongoing study. This makes our study the first to investigate the impact of COVID-19 216 on frailty and on physical and cognitive performance in older residents who survive SARS-CoV-2 infection. 217

Limitations, however, are the small sample size, which affects the statistical power of our analyses (study 218 power 0.75 for incident frailty and <0.10 for cognitive decline), and the unavailability of details on the single 219 chronic diseases presented by the study participants. Moreover, the use of age and not of a propensity score 220 to match cases and controls may represent a further limitation of our work. Nonetheless, we considered a 221 relatively homogeneous population of nursing home residents, who, differently from the community-222 dwelling, present a high prevalence of chronic conditions, such as multimorbidity, polypharmacy, and 223 disability. The high prevalence of such conditions likely made the matching process based on age similar to 224 what potentially would have obtained with a propensity score, as confirmed by comparing the baseline 225 characteristics of cases and selected controls. 226

COVID-19 may place a considerable burden on older people's health not only in terms of mortality, but also 229 in terms of worsening frailty and physical function among survivors of the disease. This effect may translate 230 into an acceleration of around 20% in the ongoing aging process. Moreover, our study revealed the 231 detrimental effect of the preventive measures put in place in the nursing home, such as physical distancing 232 and the cessation of routine leisure activities, on the cognitive status of older residents, regardless of whether 233 they were infected with SARS-CoV-2 or not. These findings highlight the importance of maintaining daily 234 activities, even in alternative forms, to ensure that institutionalized individuals receive adequate physical and 235 cognitive stimulation. Unlike the first wave of the pandemic, which found nursing homes and healthcare 236 systems generally unprepared for such an emergency and resulted in restrictive preventive measures being 237 put in place, the second wave of SARS-CoV-2 cases poses a challenge to maintaining the best standards of 238 medical and nursing care, in terms of both clinical health and psychological and physical well-being. Notes: characteristics associated with incident frailty and cognitive decline (defined as a reduction in Mini-Mental State Examination score >2 points from pre-to post-COVID assessments) were evaluated through logistic regression models. Independent variables included COVID-19, age, sex, CIRS-Comorbidity Index and, only for cognitive decline, frailty at the pre-COVID assessment.

n (%) Non-frail (Frail-NH score 0-1)

Mild or moderate frailty (Frail-NH score 2-5)

Most frail (Frail-NH score 6-14)

Cumulative Illness Rating Scale; IQR, Interquartile Range; MMSE, Mini-Mental State 348 Examination; SD